AQUINOX PHARMACEUTICALS, INC Uncategorized Contracts & Agreements
10 Contracts & Agreements
- Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 18, 2024)
- Contingent Value Rights Agreement, dated December 18, 2023, by and among Neoleukin Therapeutics, Inc., Equiniti Trust Company, LLC and Donna Cochener (Filed With SEC on December 19, 2023)
- Form of Revised CVR Agreement (Filed With SEC on December 4, 2023)
- Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 12, 2020)
- Form of Lock-Up Agreement, by each of the parties named in each agreement therein (Filed With SEC on August 6, 2019)
- Form of Support Agreement, by and among Aquinox Pharmaceuticals, Inc., Neoleukin Therapeutics, Inc. and each of the parties named in each agreement therein (Filed With SEC on August 6, 2019)
- Agreement (Filed With SEC on March 14, 2016)
- AQUINOX PHARMACEUTICALS, INC. $25,000,000 SALESAGREEMENT (Filed With SEC on April 1, 2015)
- David Main (Filed With SEC on January 28, 2014)
- SCHEDULE A AQUINOX PHARMACEUTICALS INC. AQUINOX PHARMACEUTICALS (USA) INC. OPTION AGREEMENT (Filed With SEC on January 28, 2014)
